MSF urges government authorities to include patented drugs in upcoming NLEM
Also recommends inclusion of different formulations of insulin in the upcoming NLEM
Author
Discord between IMA and MSN Labs over promotion of COVID-19 drug, Favilow
The doctors’ body claims misuse of its identity in the drug’s promotion while the pharma firm asserts that it has email expressing…
We are prepared to take on significant volumes from pharma partners working on COVID-19 vaccines
Megan Williamson, Head of Sales, Americas Datwyler elaborates how Datwyler is gearing up to meet the requirements of pharma…
Patient activist groups express relief over pause of Covishield trials in India
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety
KSRPO asks government to bring in centralised drug enforcement department
Highlights need for uniformity in designations and functioning mechanisms of all state FDAs
DCGI instructs industry to follow defined pathways for application submission of rational FDCs
It gives six months to the manufacturers to submit the applications
NPPA is readying mechanism to ease COVID-19 vaccine supply, prevent unethical practices
The government is in talks with experts and stakeholders to increase access to COVID-19 vaccines, bring down their costs and…
UPSIDA organises webinar to attract investors for proposed bulk drug park in Lalitpur
State authorities highlight initiatives that will be taken to create advantages for investors; stakeholders recommend measures to…
PCI to revamp Pharm D curriculum
Plans to release draft for comments and suggestions by the end of October 2020
COVID-19 slashes pharma production in Uttarakhand
Hoping for revival, pharma units based in Haridwar plan to start 100 per cent production from next week